Coprimary end points were rates of overall and progression-free survival.
共同的初级终点指标为总生存率和无进展生存率。
All 185 patients were included in the analysis of progression-free and overall survival.
全部185名患者参与了无疾病进展及总体生存的分析。
To determine which radiotherapy regimens for oral cavity and oropharyngeal cancers result in increased overall survival, disease free survival, progression free survival and locoregional control.
确定何种口腔及口咽癌的放射治疗方式能够增加整体存活、无病存活、无疾病进展存活以及局部区域控制。
Results: of 33 evaluated patients, a 70% overall response rate (complete response plus complete response unconfirmed, 45%) and a median progression-free survival (PFS) of 16.5 months were achieved.
结果：在33个被评估的病人中，总的反应率为70%(完全反应率加未确定的完全反应率，45%)，中位无进展生存期为16.5个月。
The primary end point was progression-free survival; secondary end points included the objective response rate, overall survival, and safety.
主要研究终点为无进展生存（PFS），次级研究终点包括客观有效率、总生存和安全性。
Overall survival and progression-free survival also did not differ in the two groups, the researchers note.
研究人员提到，在两组中总生存期和无进展生存也没有差异。
Overall survival and progression-free survival also did not differ in the two groups, the researchers note.
研究人员提到，在两组中总生存期和无进展生存也没有差异。
应用推荐